Immune mechanisms in medium and large-vessel vasculitis. - Wikidata - wikimedia - TriplyDB

Immune mechanisms in medium and large-vessel vasculitis.

Immune mechanisms in medium and large-vessel vasculitis.

http://www.wikidata.org/entity/Q34777943

about

Macrophages in vascular inflammation--From atherosclerosis to vasculitis Inflammation in arterial diseases Clinical practice. Giant-cell arteritis and polymyalgia rheumatica Giant Cell Arteritis and Polymyalgia Rheumatica: 2016 Update Endothelial Response to Glucocorticoids in Inflammatory Diseases Immune-mediated vascular injury and dysfunction in transplant arteriosclerosis A candidate gene approach identifies an IL33 genetic variant as a novel genetic risk factor for GCA East Coast Fever Caused by Theileria parva Is Characterized by Macrophage Activation Associated with Vasculitis and Respiratory Failure.In search of a candidate pathogen for giant cell arteritis: sequencing-based characterization of the giant cell arteritis microbiome.T cell-macrophage interactions and granuloma formation in vasculitis.Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis.A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility.Temporal phenotypic features distinguish polarized macrophages in vitro Accelerated atherosclerosis in patients with chronic inflammatory rheumatologic conditions Tertiary Lymphoid Organs in Takayasu Arteritis.Neglected for too long? - CD8+ Tregs release NOX2-loaded vesicles to inhibit CD4+ T cells NADPH oxidase deficiency underlies dysfunction of aged CD8+ Tregs.Giant Cell Arteritis: From Pathogenesis to Therapeutic Management.Predictors of relapse and treatment outcomes in biopsy-proven giant cell arteritis: a retrospective cohort study.Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy.Serum Cytokine Profile in Asian Indian Patients with Takayasu Arteritis and its Association with Disease Activity.IL-6 biology: implications for clinical targeting in rheumatic disease.Parietal and intravascular innate mechanisms of vascular inflammation.Immune- and ribosome-related genes were associated with systemic vasculitis.MDS and GCA: a prognostic dilemma.Giant Cell Arteritis: Beyond Corticosteroids.New insights into the pathogenesis of giant cell arteritis and hopes for the clinic.Interleukin-9 and T helper type 9 cells in rheumatic diseases.Immune checkpoint dysfunction in large and medium vessel vasculitis.The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease.F-18 FDG PET/CT imaging of cardiac and vascular inflammation and infection.Giant Cell Arteritis - Beyond temporal artery biopsy and steroids.Pro-inflammatory and anti-inflammatory T cells in giant cell arteritis.Identification of IL-23p19 as an endothelial proinflammatory peptide that promotes gp130-STAT3 signaling.Herpes Zoster as a Risk Factor for Incident Giant Cell Arteritis.[Off-label biological therapies in patients with large vessel vasculitis and/or polymyalgia rheumatica : Safety and efficacy analysis of a nationwide German registry (GRAID2)].[Large vessel vasculitis].Characteristics of autoantibodies targeting 14-3-3 proteins and their association with clinical features in newly diagnosed giant cell arteritis.Retrospective analysis of 95 patients with large vessel vasculitis: a single center experience.IL-17 production by CSF lymphocytes as a biomarker for cerebral vasculitis.

P2860

Q26825052-5381A321-4085-4ECB-A1F3-5131E8486662 Q26853576-2B6E4DAE-AA16-4319-A7D2-8CBEE5E82532 Q27005821-2F34A58B-1D02-41AC-8E60-5879C40E21F7 Q28070137-EFDD8638-BB57-4A9F-AF77-7B7D5435FD41 Q28073947-84926FEE-755E-47A4-AFA3-234820965A3F Q28084366-A771D3D7-3656-4C38-9E50-3F7B6F7DA3A2 Q28545058-B69AF149-5EC6-4878-8660-C86EAB9C6384 Q33432352-1DDC8811-8DD7-4212-9830-EA7D2AF4310E Q33961215-A87654CB-1FBE-4944-A3E1-B732C2F531C9 Q34171890-B645DF2E-F6CC-4E43-9B7A-F542E54B4B0E Q34579101-6EB134AC-4448-43CA-AB6E-B0D8B3E3A024 Q35266391-FDE80E51-BF12-4EA1-BEF5-C2297A4223BF Q36377797-B39341CB-F504-48DB-BFDF-03500DEAD4E3 Q36746012-879DBBC9-FD67-42DC-862F-9CD0527A2D09 Q36823653-C1FEECA1-8C23-435A-9C13-A3597AF94B0B Q36867336-5AE66F62-D3AD-4AA6-AEAB-BEACEFABFAC9 Q36867379-2A9E0B54-564A-4E74-9941-172705048B31 Q36992669-8D74F1F2-753D-41CE-8D19-9FDB349AC9FE Q37082033-7D89FABC-2483-4DB9-BE8C-B9B2F14A629A Q37691169-F6535459-924B-4B36-AC20-E8CA13B7890E Q37721330-E520001E-2D03-47B0-8616-81100D84B38F Q38241232-B27FA1AB-CACE-4C33-BC74-A45FF581E187 Q38427670-6EA3CFCC-4BEC-439F-BB6D-1F326667806C Q38470347-95450DCB-8011-406F-9AA4-1D3CA211DB5A Q38529556-D2B9341C-9377-4143-A8C3-C3BD103C094D Q38560322-68D3DDCE-25EC-4E6E-AC67-008407686C99 Q38586408-893F9EF8-3BD4-4E62-B0F4-07EB79D0C338 Q38829766-C8387C07-5505-42F9-A4C0-AFB1C81C2054 Q38897019-25DD5763-28D6-44B7-B6C8-FD3C35344382 Q38915556-00B51B5F-70FC-446B-A798-7A72BAE9C563 Q38950827-979F7BF3-3EF2-4E2C-8ABE-6E71DF8F145B Q39293033-DFD4265B-C74B-4452-88D9-4CE12CC90DCA Q39356029-BB90AB34-228A-4792-AD5D-81468C42DA3F Q39918063-F8697251-815E-4630-898D-5D5063E9915D Q40065347-0A757509-AD9F-41B1-8870-4BA0AB8F00EF Q40201293-76935CAE-1E17-453D-8EF3-F26DE8AC66AC Q40203869-963F70FD-93C1-49D5-A40D-A38355903496 Q40381133-FE2B4F62-0977-4D32-8BC7-1DC5AAB8A5BF Q40459457-A1BC82F8-EC91-4F68-93A0-08BC1465BCED Q40513572-61BCD4A8-12AA-4169-BD29-F9FBECCA2005

P2860

Immune mechanisms in medium and large-vessel vasculitis.

http://www.wikidata.org/entity/Q34777943

description

2013 nî lūn-bûn

@nan

2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

name

Immune mechanisms in medium and large-vessel vasculitis.

@ast

Immune mechanisms in medium and large-vessel vasculitis.

@en

Immune mechanisms in medium and large-vessel vasculitis.

@nl

type

label

Immune mechanisms in medium and large-vessel vasculitis.

@ast

Immune mechanisms in medium and large-vessel vasculitis.

@en

Immune mechanisms in medium and large-vessel vasculitis.

@nl

prefLabel

Immune mechanisms in medium and large-vessel vasculitis.

@ast

Immune mechanisms in medium and large-vessel vasculitis.

@en

Immune mechanisms in medium and large-vessel vasculitis.

@nl

P1433

Q34777943-6FE47612-4811-4D84-9526-A2BFC5C09295

P1476

Q34777943-1CC47096-4CB5-4382-B525-0219DB2CA8CE

P2093

Q34777943-5DD7616C-495F-40BE-90F7-4D906DD97269

Q34777943-EDB2C917-2B9A-4EA4-85D2-249B9FA8F4CA

P2860

Q34777943-00A7D356-A129-46FD-9740-348CD8882917

Q34777943-02630F8A-25F4-419A-ABC8-5C760998D96E

Q34777943-0267DFD4-BDE0-4D60-939B-08455B1E92BB

Q34777943-06595E06-E277-4C28-8F34-3287530E1CF6

Q34777943-09A5D271-FD3B-4E37-8EC8-FDEAF24AB342

Q34777943-0ADF8C44-BE79-41A2-B38B-48F10D2E2DC5

Q34777943-0AF5FE53-CC5E-4D44-A6D5-102300E36F30

Q34777943-0B7DA192-9783-4897-BB9C-A7D4A75237FE

Q34777943-18284667-484F-4147-BA5E-550470ECC49F

Q34777943-1FC816BB-BDE1-4C0B-A1FB-63EEA20B4585

P2888

Q34777943-11146DB4-8F53-4192-84C5-93166A4BCCD2

P304

Q34777943-13B7E5BB-9C9E-4E22-A465-9275AD409A1C

P31

Q34777943-64CE97F0-F499-487F-B0CD-D7448E8E1FC7

P356

Q34777943-12870062-091A-4729-8FEB-10A31F54C2A8

P407

Q34777943-22993691-605C-4575-9ED7-8A4642F9E290

P433

Q34777943-D34ECC03-A3AD-4A73-9E9F-4FD515F9456D

P478

Q34777943-0A4F706E-8231-4EE2-BC18-06C41D03B73E

P577

Q34777943-9D4CDEB3-4F4F-4E1E-975B-129A4A10EB66

P5875

Q34777943-76E9EC12-ED7A-480B-8ED5-40F6E53B26AF

P6179

Q34777943-4B1A4981-C2EF-400B-952C-5154E2AA319C

P698

Q34777943-709960A4-D5E8-4D5D-94F7-AFAD0D7298AA

P932

Q34777943-6AD84202-43A2-4BBB-AB68-7EB3E1D420E9

P356

NRRHEUM.2013.161

P1433

Nature Reviews Rheumatology

P1476

Immune mechanisms in medium and large-vessel vasculitis.

@en

P2093

Cornelia M Weyand

http://www.w3.org/2001/XMLSchema#string

Jörg J Goronzy

http://www.w3.org/2001/XMLSchema#string

P2860

Pediatric vasculitis

The adventitia: essential regulator of vascular wall structure and function

Participation of blood vessel cells in human adaptive immune responses

The immunopathology of giant cell arteritis: diagnostic and therapeutic implications

Medium- and large-vessel vasculitis

2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

Interferon-gamma axis in graft arteriosclerosis

Genomic responses in mouse models poorly mimic human inflammatory diseases

Notch signalling: a simple pathway becomes complex

The CC chemokine CCL20 and its receptor CCR6.

P2888

nrrheum.2013.161

P304

731-740

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRRHEUM.2013.161

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258281358

http://www.w3.org/2001/XMLSchema#string

P6179

1019978835

http://www.w3.org/2001/XMLSchema#string

P698

24189842

http://www.w3.org/2001/XMLSchema#string

P932

4277683

http://www.w3.org/2001/XMLSchema#string